Rufino Silva, MD, PhD, Professor of Ophthalmology at the University of Coimbra, Portugal, speaks about the results of the the ATLANTIC study, a multicentered randomized clinical trial performed on a Caucasian population with polypoidal choroidal vasculopathy (PCV). Patients were treated with T&E aflibercept, with or without additional photodynamic therapy (PDT).